A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/14/2002	CA2446795A1 Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands
11/14/2002	CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002	CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002	CA2446480A1 Method of preventing cell death using antibodies to neural thread proteins
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446396A1 N-aroyl cyclic amines
11/14/2002	CA2446365A1 Sulfonamides
11/14/2002	CA2446363A1 Potentiation of therapeutic effects of fatty acids
11/14/2002	CA2446351A1 Fused heterocyclic compounds
11/14/2002	CA2446234A1 Alpha-2-adrenergic agonist/fatty acid compositions
11/14/2002	CA2446120A1 Novel arylheteroalkylamine derivatives
11/14/2002	CA2446087A1 Recombinant tumor specific antibody and use thereof
11/14/2002	CA2446051A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	CA2445679A1 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	CA2445634A1 Acne treatment comprising lipoxygenase inhibitors
11/14/2002	CA2445065A1 Trimethyl lock based tetrapartate prodrugs
11/14/2002	CA2444531A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002	CA2444013A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/14/2002	CA2442969A1 Methods for selective immunomodulation using pimecrolimus
11/14/2002	CA2385809A1 Alkylamide compounds
11/13/2002	EP1256583A1 Pyrimidine-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
11/13/2002	EP1256582A1 1h-imidazopyridine derivatives
11/13/2002	EP1256578A1 Thiazole derivatives and their use as cdk inhibitors
11/13/2002	EP1256351A1 Novel immune enhancing compositions
11/13/2002	EP1256349A1 Cell activator
11/13/2002	EP1256342A1 Hypoglycemics comprising organic zinc (ii) complexes
11/13/2002	EP1256339A1 Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
11/13/2002	EP1255870A2 5-hydroxytryptamine transporter gene polymorphisms
11/13/2002	EP1255854A2 Interaction of nmda receptor with protein tyrosine phosphatase
11/13/2002	EP1255853A2 Methods of protein destabilization and uses thereof
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255834A2 Gtpase activating proteins
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255827A2 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255813A1 Multipotent neural stem cells from peripheral tissues and uses thereof
11/13/2002	EP1255760A1 Clavams as protease inhibitors
11/13/2002	EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002	EP1255756A1 Saccharin derivatives as orally active elastase inhibitors
11/13/2002	EP1255755A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/13/2002	EP1255753A2 Prodigiosin-derivatives as neoplastic and anti-viral agents
11/13/2002	EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002	EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002	EP1255749A1 Tyrosine derivatives with anti-leukotriene activity
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255746A1 Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity
11/13/2002	EP1255744A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof
11/13/2002	EP1255742A1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
11/13/2002	EP1255740A2 Substituted arylpyrazines
11/13/2002	EP1255733A1 Farnesyl transferase inhibitors
11/13/2002	EP1255564A2 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
11/13/2002	EP1255559A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1255556A2 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
11/13/2002	EP1255553A2 Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers
11/13/2002	EP1255552A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/13/2002	EP1255551A1 Use of paullone derivatives for making medicines
11/13/2002	EP1255550A2 Method for identifying and using a 2b adenosine receptor antagonists to mediate mammalian cell proliferation
11/13/2002	EP1255546A1 Method for improving bone modeling and chondrocyte functioning in growing canines
11/13/2002	EP1255544A1 Mucin synthesis inhibitors
11/13/2002	EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002	EP1255539A1 Use of alpha 1a? adrenoceptor agonists with alpha 1b? and alpha 1d? antagonism for the treatment of stress urinary incontinence
11/13/2002	EP1255538A2 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
11/13/2002	EP1255537A2 Farnesyl protein transferase inhibitors for treating breast cancer
11/13/2002	EP1255536A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
11/13/2002	EP1140916B1 Heteroaryl-cyclic acetals
11/13/2002	EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/13/2002	EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002	EP1012139B1 Azetidinone derivatives as beta-lactamase inhibitors
11/13/2002	EP0977575B1 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
11/13/2002	EP0949921B1 Thrombin inhibitors
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002	EP0735863B1 Accelerated release composition containing bromocriptine
11/13/2002	EP0699074B1 Thrombin inhibitors
11/13/2002	EP0693935B1 Method and compositions for digesting tissue
11/13/2002	CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions
11/13/2002	CN1379785A Caspase inhibitors for treatment and prevention of chemotherapy and radiation therapy induced cell death
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/13/2002	CN1379776A Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
11/13/2002	CN1379774A Compounds
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379767A Isoxazolecarboxamide derivatives
11/13/2002	CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/13/2002	CN1379752A Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use

1 ... 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 ... 1564